AVIR logo

Atea Pharmaceuticals (AVIR) Company Overview

Profile

Full Name:

Atea Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 30, 2020

Indexes:

Not included

Description:

Atea Pharmaceuticals is a biopharmaceutical company focused on developing antiviral therapies. They aim to create innovative treatments for viral infections, particularly COVID-19. Their research combines advanced technology and scientific expertise to improve patient outcomes and address unmet medical needs in infectious diseases.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Aug 13, 24 Morgan Stanley
Equal-Weight
Aug 10, 23 JP Morgan
Underweight
Mar 16, 23 JP Morgan
Neutral
Jan 27, 23 SVB Leerink
Market Perform
Jan 24, 23 Morgan Stanley
Underweight
Aug 15, 22 Morgan Stanley
Underweight
Mar 2, 22 JP Morgan
Neutral
Mar 1, 22 SVB Leerink
Market Perform
Feb 16, 22 SVB Leerink
Market Perform
Jan 6, 22 Morgan Stanley
Underweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Atea Pharmaceuticals?
  • Does Atea Pharmaceuticals pay dividends?
  • What sector is Atea Pharmaceuticals in?
  • What industry is Atea Pharmaceuticals in?
  • What country is Atea Pharmaceuticals based in?
  • When did Atea Pharmaceuticals go public?
  • Is Atea Pharmaceuticals in the S&P 500?
  • Is Atea Pharmaceuticals in the NASDAQ 100?
  • Is Atea Pharmaceuticals in the Dow Jones?
  • When was Atea Pharmaceuticals's last earnings report?
  • When does Atea Pharmaceuticals report earnings?
  • Should I buy Atea Pharmaceuticals stock now?

What is the ticker symbol for Atea Pharmaceuticals?

The ticker symbol for Atea Pharmaceuticals is NASDAQ:AVIR

Does Atea Pharmaceuticals pay dividends?

No, Atea Pharmaceuticals does not pay dividends

What sector is Atea Pharmaceuticals in?

Atea Pharmaceuticals is in the Healthcare sector

What industry is Atea Pharmaceuticals in?

Atea Pharmaceuticals is in the Biotechnology industry

What country is Atea Pharmaceuticals based in?

Atea Pharmaceuticals is headquartered in United States

When did Atea Pharmaceuticals go public?

Atea Pharmaceuticals's initial public offering (IPO) was on October 30, 2020

Is Atea Pharmaceuticals in the S&P 500?

No, Atea Pharmaceuticals is not included in the S&P 500 index

Is Atea Pharmaceuticals in the NASDAQ 100?

No, Atea Pharmaceuticals is not included in the NASDAQ 100 index

Is Atea Pharmaceuticals in the Dow Jones?

No, Atea Pharmaceuticals is not included in the Dow Jones index

When was Atea Pharmaceuticals's last earnings report?

Atea Pharmaceuticals's most recent earnings report was on Nov 7, 2024

When does Atea Pharmaceuticals report earnings?

The next expected earnings date for Atea Pharmaceuticals is Feb 28, 2025

Should I buy Atea Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions